Biologics: Targets and Therapy- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details

About Biologics: Targets and Therapy

Biologics: Targets and Therapy is a journal published by Dove Medical Press Ltd. This journal covers the area[s] related to Gastroenterology, Pharmacology (medical), Immunology and Allergy, Oncology, Rheumatology, etc. The coverage history of this journal is as follows: 1988, 2007-2026. The rank of this journal is 4981. This journal's impact score, h-index, and SJR are 4.37, 53, and 0.989, respectively. The ISSN of this journal is/are as follows: 11775491, 11775475.

The best quartile of Biologics: Targets and Therapy is Q1. This journal has received a total of 318 citations during the last three years (Preceding 2025).

Biologics: Targets and Therapy Impact Score 2025-2026

The latest impact score (IS) of the Biologics: Targets and Therapy is 4.37. It is computed in the year 2026 as per its definition and based on Scopus data. 4.37

It is increased by a factor of around 1.14, and the percentage change is 35.29% compared to the preceding year 2024, indicating a rising trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Prediction of Biologics: Targets and Therapy Impact Score 2026

Impact Score 2025 of Biologics: Targets and Therapy is 4.37. If a similar upward trend continues, IS may increase in 2026 as well.

Biologics: Targets and Therapy h-index

 

The h-index of Biologics: Targets and Therapy is 53. By definition of the h-index, this journal has at least 53 published articles with more than 53 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.

Biologics: Targets and Therapy ISSN

The International Standard Serial Number (ISSN) of Biologics: Targets and Therapy is/are as follows: 11775491, 11775475.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Biologics: Targets and Therapy Ranking and SCImago Journal Rank (SJR)

The Biologics: Targets and Therapy is ranked 4981 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.989.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

Biologics: Targets and Therapy Publisher

The publisher of Biologics: Targets and Therapy is Dove Medical Press Ltd. The publishing house of this journal is located in the New Zealand. Its coverage history is as follows: 1988, 2007-2026.

Call For Papers (CFPs)

Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).

Abbreviation

The International Organization for Standardization 4 (ISO 4) abbreviation of Biologics: Targets and Therapy is Biol.: Targets Ther.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Biol.: Targets Ther.') can be used for citing, indexing, abstraction, and referencing purposes.

How to publish in Biologics: Targets and Therapy

If your area of research or discipline is related to Gastroenterology, Pharmacology (medical), Immunology and Allergy, Oncology, Rheumatology, etc., please check the journal's official website to understand the complete publication process.

Acceptance Rate

There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

• Interest/demand of researchers/scientists for publishing in a specific journal/conference.
• The complexity of the peer review process and timeline.
• Time taken from draft submission to final publication.
• Number of submissions received and acceptance slots
• And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.

Credits and Sources

• Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
• Journal Impact Factor, https://clarivate.com/
• Issn.org, https://www.issn.org/
• Scopus, https://www.scopus.com/